Two pharmaceutical companies on Sept. 17 denied a report saying they had splurged 50 billion yuan (US$8.1 billion) on the purchase of a traditional Chinese medical formula that is touted as a cure for liver cancer, the Guangzhou-based 21st Century Business Herald reports. The paper said a Hong Kong merchant who claimed he represented “Germany-based US pharmaceutical giant Merck” tried to buy a patent for a prescription for a liver cancer treatment from the Anhui-based Jinfang Huaixia Traditional Chinese Medicine Research Center.
Help employers find you! Check out all the jobs and post your resume.
